Drug Type Biological products |
Synonyms |
Target- |
Mechanism Cell replacements |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization Avenge Bio, Inc.Startup |
Active Organization- |
Inactive Organization Avenge Bio, Inc.Startup |
Drug Highest PhaseDiscontinuedDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Discovery | US | Avenge Bio, Inc.Startup | 21 Jan 2022 |